Gelstat Corp SEC filings GSAC
Gelstat Corp has 190 filings in SEC EDGAR's recent list, going back to Jun 14, 1996. Its latest annual report, Form 10-K, was filed on Oct 22, 2012 for the period ended Dec 31, 2008. The latest quarterly report (Form 10-Q) was filed on Oct 22, 2012, covering the quarter ended Sep 30, 2008. The most recent current report (Form 8-K) was filed on May 2, 2007 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Jul 12, 2004 | Aug 12, 2004 |
| DEF 14A | Proxy statement | Jun 16, 2003 | Jul 14, 2003 |
| PRE 14A | Preliminary proxy statement | Jun 3, 2003 | Jul 14, 2003 |
| DEF 14A | Proxy statement | Apr 27, 2000 | Dec 31, 1999 |
| DEF 14A | Proxy statement | Oct 13, 1999 | Dec 31, 1998 |
| DEF 14A | Proxy statement | Mar 23, 1998 | Apr 14, 1998 |
| DEFA14A | Additional proxy material | Apr 9, 1997 | — |
| DEF 14A | Proxy statement | Feb 27, 1997 | Apr 24, 1997 |
Showing 8 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- GSAC (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Miami, FL
- SEC CIK
- 890725
- Former names
- DEVELOPED TECHNOLOGY RESOURCE INC (until Jul 15, 2003)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.